Amentum reported third-quarter fiscal 2026 revenue of $3,490 million, down 2% from $3,561 million a year earlier, while GAAP net income rose to $66 million from $10 million and adjusted diluted EPS rose to $0.67 from $0.56. The company raised its fiscal 2026 guidance for Adjusted EBITDA and adjusted diluted EPS but cut its revenue guidance, so shareholders see mixed signals on the year.
Revenue of $3,490 million fell 2% year over year; diluted EPS was $0.27 versus $0.04 and Adjusted EBITDA was $290 million, up 6%.
Free cash flow was $135 million, up 35% from $100 million; backlog reached $48.2 billion, up 8%.
FY2026 revenue guidance was cut to $13,800-$13,950 million from $13,950-$14,300 million.
FY2026 Adjusted EBITDA guidance was raised to $1,115-$1,140 million and adjusted diluted EPS guidance to $2.40-$2.50 from $2.25-$2.45.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Amentum's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$14.39B
+71.6%
$0.27
—
0.5%
FY2024
$8.39B
+6.6%
$-0.90
—
-1.0%
FY2023
$7.87B
+2.5%
$-3.49
—
-4.0%
FY2022
$7.68B
—
$-0.93
—
-1.1%
Frequently asked questions
When is Amentum's next earnings date?
Amentum (AMTM) is scheduled to report on Monday, November 23, 2026 after the market closes. Analysts expect EPS of $0.63.
What did Amentum earn last quarter?
For the quarter ended Jul 2026, Amentum reported diluted EPS of $0.27 (+575.0% year over year) on revenue of $3.49B (-2.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.